Publications by authors named "Giorgio Cignarella"

Claim this Profile
S
Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety.
Gérard A Pinna, Gabriele Murineddu, Caterina Murruzzu, Valentina Zuco, Franco Zunino, Giorgio Cignarella

ChemMedChem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors.
Giovanni Loriga, Ilaria Manca, Gabriele Murineddu, Giorgio Chelucci, Stefania Villa, Giorgio Cignarella

Bioorg Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
Amedeo Leonardi, Daniela Barlocco, Federica Montesano, Giorgio Cignarella, Gianni Motta

J Med Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
M Paola Castelli, Luca Ferraro, Ignazia Mocci, Francesca Carta, Mauro A M Carai, Giorgio Cignarella

J Neurochem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3' allyl end and at the phenyl ring of the cinnamyl chain on mu-receptor affinity and opioid antinociception.
Gérard Aimè Pinna, Giorgio Cignarella, Stefania Ruiu, Giovanni Loriga, Gabriele Murineddu

Bioorg Med Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congo red analogues as potential anti-prion agents.
Stefania Villa, Giorgio Cignarella, Daniela Barlocco, Marco Gervasoni, Gabriella Carcassola

Farmaco· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Chloropyridazin-3-yl derivatives active as nicotinic agents: synthesis, binding, and modeling studies.
Lucio Toma, Paolo Quadrelli, William H Bunnelle, David J Anderson, Michael D Meyer, Giorgio Cignarella

J Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modifications.
Gérard A Pinna, Giorgio Cignarella, Giovanni Loriga, Gabriele Murineddu, Jean Mario Mussinu

Bioorg Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives.
Gabriele Murineddu, Giorgio Cignarella, Giorgio Chelucci, Giovanni Loriga, Gérard Aimè Pinna

Chem Pharm Bull (Tokyo)· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain.
M Paola Castelli, Ignazia Mocci, Marco Pistis, Michela Peis, Daniela Berta, Giorgio Cignarella

Eur J Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid.
Mauro A M Carai, Giancarlo Colombo, Roberta Reali, Salvatore Serra, Ignazia Mocci, Giorgio Cignarella

Eur J Pharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis